Consensus Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Equities

Real-time Estimate Tradegate Other stock markets 08:01:41 26/06/2024 pm IST			5-day change	1st Jan Change
85.55 ^EUR	-1.44%		0.00%	+43.00%

02:44pm	Rovi receives non-binding offers for manufacturing business	RE
08/05	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

9d.AbdeHcX7879btdCe8upcyR5ukwN0eEIjJUkZzk3OHAw.T947dqiym88J_5vutq8yomo46W0YPil6aSBdvjy_VDRrjgtR6JeyzwuFlQ~f67f2cc0bf3f511e46a15ba4cf7240d0

23/22/23

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

83 EUR

Average target price

91.31 EUR

Spread / Average Target

+10.02%

High Price Target

100.5 EUR

Spread / Highest target

+21.08%

Low Price Target

83 EUR

Spread / Lowest Target

0.00%

Trading Rating

Investor Rating

ESG Refinitiv